Speak directly to the analyst to clarify any post sales queries you may have.
There will be an increase in demand for Insulin Pens in the forecast period due to its long-term cost-effectiveness and other advantages such as accuracy, better convenience, and ease of use over conventional insulin pens. Other than high-income countries with full diabetes insurance coverage, several middle-income countries have started adopting it with advanced technologies. In some countries in Europe, for example, France, Spain, and Germany, doctors highly prescribe insulin pens under the health insurance coverage with a reasonable cutting cost, which makes it more cost-effective than insulin syringes.
The insulin pens market is expected to grow at a CAGR of 6.26% during the forecast period
GLOBAL INSULIN PENS MARKET SEGMENTATION
- The traditional insulin pens dominated the market. However, smart insulin pens are expected to increase significantly in the forecast period across the globe.
- Hospitals & Clinics dominated the distribution channel segment because of the easy access to insulin pens in the hospital pharmacies and thus doctors are increasingly prescribing insulin pens in both high- and low-income countries.
Segmentation by Product
- Traditional
- Smart
Segmentation by Usage
- Disposable
- Reusable
Segmentation by Distribution Channel
- Hospitals & Clinics
- Standalone Pharmacies
- Online
GEOGRAPHICAL OUTLOOK
- Europe dominated the market due to high prevalence of diabetes in the region. APAC region is expected to grow at faster rate in the forecast period with the CAGR of 7.26% because of the increase in awareness and the target population.
Segmentation by Geography
- Europe
- Germany
- UK
- France
- Spain
- Italy
- North America
- US
- Canada
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
- UAE
VENDOR LANDSCAPE
The leading vendors in the insulin pen industry are Lilly, Medtronic, Novo Nordisk, and Sanofi. The market competition is solely based on quality, quantity, technology, safety, and price.
KEY VENDORS
- Lilly
- Medtronic
- Novo Nordisk
- Sanofi
OTHER PROMINENT VENDORS
- BD
- Biocon
- Diamesco
- Emperra
- Guangzhou Medsinglong Medical Equipment
- HK Zion Industry
- Jiangsu Delfu Medical Device
- Owen Mumford
- Shanghai Umitai Medical Technology
- Sun Medical Products
- Suzhou Peng Ye Medical Technology Co., Ltd.
- Triones Technology (Guangzhou)
- Ypsomed
THE REPORT INCLUDES:
1. The analysis of the global Insulin Pens market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Insulin Pens market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the global Insulin Pens market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Table of Contents
Companies Mentioned
- Lilly
- Medtronic
- Novo Nordisk
- Sanofi
- BD
- Biocon
- Diamesco
- Emperra
- Guangzhou Medsinglong Medical Equipment
- HK Zion Industry
- Jiangsu Delfu Medical Device
- Owen Mumford
- Shanghai Umitai Medical Technology
- Sun Medical Products
- Suzhou Peng Ye Medical Technology Co., Ltd.
- Triones Technology (Guangzhou)
- Ypsomed
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 260 |
Published | March 2022 |
Forecast Period | 2022 - 2027 |
Estimated Market Value ( USD | $ 1088.44 Million |
Forecasted Market Value ( USD | $ 1567.1 Million |
Compound Annual Growth Rate | 6.2% |
Regions Covered | Global |
No. of Companies Mentioned | 17 |